IBEX Technologies Inc. (IBT.V)
| Previous Close | 0.3100 |
| Open | 0.3100 |
| Bid | 0.3100 x 0 |
| Ask | 0.3800 x 0 |
| Day's Range | 0.3100 - 0.3100 |
| 52 Week Range | 0.2200 - 0.4100 |
| Volume | 2,000 |
| Avg. Volume | 8,622 |
| Market Cap | 7.68M |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 5.74 |
| EPS (TTM) | 0.0540 |
| Earnings Date | Mar. 17, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
IBEX Appoints Christine Charette to Board of Directors
MONTRÉAL, June 28, 2021 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it has appointed Christine Charette to the IBEX Board of Directors. “We are extremely pleased to welcome Christine to our Board,” said Paul Baehr, IBEX Chairman and CEO. “Her wealth of experience in business development and business strategy in the biotech world will be of great value to IBEX.” Christine Charette is the Managing Partner & Founder of Scienta Advisors
- Simply Wall St.
IBEX Technologies Inc.'s (CVE:IBT) Stock Is Going Strong: Have Financials A Role To Play?
Most readers would already be aware that IBEX Technologies' (CVE:IBT) stock increased significantly by 5.0% over the...
- GlobeNewswire
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2021
MONTRÉAL, June 17, 2021 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the nine months ended April 30, 2021. “As predicted, sales in constant dollars ($US) decreased this quarter vs year ago (-4%) which, combined with a 9% negative change in currency, translated to a 13% decline in Canadian dollars for the quarter. Despite this decrease, year to date we are running five percent higher than last year,” said Paul Bae
